|
|
Post by pguererro on Feb 26, 2020 20:23:53 GMT -5
There are so many naive comments on this site regarding real world choices for today’s doctor and treating diabetes I stopped righting down notes on who to respond to and how. I started this by telling u a fact. U guys haven’t talked to multiple patients and multiple prescribers about Afrezza. Hell double down on your investment. Mike will spin a new thread at the next big conference. Also, VDEX Is a losing proposition as well (sorry Sports). It’s Afrezza
|
|
|
|
Post by nylefty on Feb 26, 2020 20:31:18 GMT -5
From Steve.... Stephen Brown Vice president Vdex diabetes Real simple math... 350(avg new patients per week)X 52 (wks in yr) =18,200 x 4yrs= 72,800 patients. (Approximate) MNKD says there are 5-6k patients now. 7280 patients would speak to a drop rate of over 90%. Simple And that is not subtracting those patients that were in the trials and stayed and those from Sanofi. They can't sell Afrezza because of all the things he/she is saying, which we have all discussed before. Drs are not putting T2s on insulin or anyone else when they have another choice. VDEX trains/educates this out of it's providers. Al made this for Everyone! Especially T2s. Afrezza works like a dream on all types!!! VDEX sees T1s/T2s at around the national averages...7% vs 93%. (snip) SDB I'm a VDEX supporter, but Steve is wrong about the number of "new patients" on Afrezza. The 350 average NRx number is for new scripts, not new patients. MC says that only about 25 percent of the "new" prescriptions are for new patients. Assuming that's true, the rest are for dosage changes and yearly renewals. |
|
|
|
Post by sweedee79 on Feb 26, 2020 20:34:12 GMT -5
There are so many naive comments on this site regarding real world choices for today’s doctor and treating diabetes I stopped righting down notes on who to respond to and how. I started this by telling u a fact. U guys haven’t talked to multiple patients and multiple prescribers about Afrezza. Hell double down on your investment. Mike will spin a new thread at the next big conference. Also, VDEX Is a losing proposition as well (sorry Sports). It’s Afrezza Don't know how you can simply say "it's Afrezza".. I have had real world experience.. and it's been entirely positive.. You had my ear right up until now. You sound like a closed minded basher. Are you a sales rep with Mnkd? |
|
|
|
Post by mango on Feb 26, 2020 20:35:04 GMT -5
From Steve.... Stephen Brown Vice president Vdex diabetes Real simple math... 350(avg new patients per week) X 52 (wks in yr) =18,200 x 4yrs= 72,800 patients. (Approximate) MNKD says there are 5-6k patients now. 7280 patients would speak to a drop rate of over 90%. Simple And that is not subtracting those patients that were in the trials and stayed and those from Sanofi. They can't sell Afrezza because of all the things he/she is saying, which we have all discussed before. Drs are not putting T2s on insulin or anyone else when they have another choice. VDEX trains/educates this out of it's providers. Al made this for Everyone! Especially T2s. Afrezza works like a dream on all types!!! VDEX sees T1s/T2s at around the national averages...7% vs 93%. We get them in control and approved. Getting a T2 approved for CGM/Afrezza/appointments is always tougher but the results that are possible with Afrezza, really make a huge impact on the argument that one can make to Ins. Simplified dosing is KEY Knowing what pitfalls await the patient and a clear and confident way to warn and educate the patient prior is essential. Knowing what Afrezza is capable of is most important of all. Without that, they will undervalue and underuse and fail to get the best Afrezza has to offer. "It's ok" "good for corrections" Rest assured, Afrezza is everything and more that Al said it was. It's not going anywhere... It's going everywhere! SDB Hell yeah! How many patients does Vdex currently manage? |
|
|
|
Post by ktim on Feb 26, 2020 20:35:17 GMT -5
From Steve.... Stephen Brown Vice president Vdex diabetes Real simple math... 350(avg new patients per week) X 52 (wks in yr) =18,200 x 4yrs= 72,800 patients. (Approximate) MNKD says there are 5-6k patients now. 7280 patients would speak to a drop rate of over 90%. Simple And that is not subtracting those patients that were in the trials and stayed and those from Sanofi. ... Seems his math is wrong, at least with regard to current situation. Per yesterday's cc... Only 25% of NRx are new patients. Dropout rate for T2 is 50%, and less for T1. |
|
|
|
Post by pguererro on Feb 26, 2020 20:43:50 GMT -5
Everybody has that 1 or 2 people they know where Afrezza changed their life. Maybe a family member...in my case an Afrezza sales rep. I’m not saying it can’t change a patients life. I’m saying after 4 years enough patients have tried it and not stayed on it. I’m not saying this to be a downer on a MNKD long site that I have faithfully watched for years. I’m just telling you true feedback and it isn’t good. I sold my stuff a long time ago after losing it all.
|
|
|
|
Post by pguererro on Feb 26, 2020 20:45:03 GMT -5
I thought Sanofi were the biggest idiots 4 years ago, but that 150 million dollar settlement was golden.
|
|
|
|
Post by sweedee79 on Feb 26, 2020 20:46:28 GMT -5
Everybody has that 1 or 2 people they know where Afrezza changed their life. Maybe a family member...in my case an Afrezza sales rep. I’m not saying it can’t change a patients life. I’m saying after 4 years enough patients have tried it and not stayed on it. I’m not saying this to be a downer on a MNKD long site that I have faithfully watched for years. I’m just telling you true feedback and it isn’t good. I sold my stuff a long time ago after losing it all. Perhaps if we're prescribed correctly patient retention.would be a whole lot better. What I've seen is that the body responds to Afrezza in a way it doesn't to RAA.. My dad's blood pressure went down.. he had more energy.. felt better. Lost 25lbs.. how do you explain that? |
|
|
|
Post by pguererro on Feb 26, 2020 20:47:43 GMT -5
You pithy responders will now say “how could you have sold it if u lost it all”. Keep investing in MNKD. And kick me off the site I’m just trying to tell u reality.
|
|
|
|
Post by pguererro on Feb 26, 2020 20:49:23 GMT -5
Sweedie: Again Naive... you don’t think the sales force has been talking about the 1.5-2 times conversion rate for over 2 yrs?
|
|
|
|
Post by mango on Feb 26, 2020 20:50:18 GMT -5
Everybody has that 1 or 2 people they know where Afrezza changed their life. Maybe a family member...in my case an Afrezza sales rep. I’m not saying it can’t change a patients life. I’m saying after 4 years enough patients have tried it and not stayed on it. I’m not saying this to be a downer on a MNKD long site that I have faithfully watched for years. I’m just telling you true feedback and it isn’t good. I sold my stuff a long time ago after losing it all. Perhaps if we're prescribed correctly patient retention.would be a whole lot better. According to him that wouldn't change anything, re: "Vdex is a losing proposition" and simply, "it's Afrezza". Doom Porn!!! Why is anyone listening to this chit? |
|
|
|
Post by sweedee79 on Feb 26, 2020 20:50:31 GMT -5
Not naive.. I've seen what Afrezza does..
|
|
|
|
Post by golfeveryday on Feb 26, 2020 20:50:35 GMT -5
Everybody has that 1 or 2 people they know where Afrezza changed their life. Maybe a family member...in my case an Afrezza sales rep. I’m not saying it can’t change a patients life. I’m saying after 4 years enough patients have tried it and not stayed on it. I’m not saying this to be a downer on a MNKD long site that I have faithfully watched for years. I’m just telling you true feedback and it isn’t good. I sold my stuff a long time ago after losing it all. Please tell me you are not a sales rep. Lol. I agree the road has been challenging. Facts are MC has not tried hard enough. Plain and simple. He selects 1990’s marketing tactics. There are many things he has not tried. I’ve worked in diabetes at a time when a new paradigm was trying to be introduced. It’s tough. He’s in denial. He should have partnered this one a long time ago, given up more in the deal than he wanted in order to press on. |
|
|
|
Post by nylefty on Feb 26, 2020 20:56:00 GMT -5
Sweedie: Again Naive... you don’t think the sales force has been talking about the 1.5-2 times conversion rate for over 2 yrs? It's been suggested that you work for MannKind, something I find impossible to believe. Do you or do you not? |
|
|
|
Post by pguererro on Feb 26, 2020 20:56:44 GMT -5
Wrong on Mike C. Extremely passionate about product and could not get in front of more influential groups. “Doom Porn”😀. Again..double down MNKD is cheap right now!!
|
|
